FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2770973170> ?p ?o ?g. }

• W2770973170 endingPage "25" @default.
• W2770973170 startingPage "13" @default.
• W2770973170 abstract "Dulaglutide is a novel onceweekly administered glucagon-like peptide 1 receptor agonist (GLP-1 RA) for the management of type 2 diabetes mellitus (T2DM). The objective of this analysis was to estimate the cost-effectiveness of dulaglutide 1.5 mg versus exenatide QW for the management of T2DM in France. The QuintilesIMS CORE Diabetes Model was used to estimate the expected lifetime direct medical costs and outcomes of T2DM from the perspective of the French National Health Service. In the absence of head-to-head data, relative efficacy was derived from a network meta-analysis. Patient cohort characteristics were derived from the AWARD-2 trial. All patients were assumed to remain on treatment for 2 years before escalating to insulin therapy. Costs included treatment costs and costs associated with long-term complications of T2DM. Utilities were estimated based on a recent systematic review. One-way sensitivity analyses (OWSA) and probabilistic sensitivity analysis (PSA) were conducted. Cost-effectiveness acceptability curves (CEACs) were generated. Dulaglutide 1.5 mg was associated with lower costs (lifetime costs €41,562 vs €43,021) and increased health benefits (lifetime quality-adjusted life years: QALYs 9.804 vs 9.757) versus exenatide QW for the treatment of T2DM in France. OWSA and PSA indicated that results were robust across a range of plausible input parameters. The CEAC indicated a 99.5% probability that dulaglutide would be considered cost-effective at a willingness to pay of €30,000. Dulaglutide 1.5 mg reduced expected costs and increased expected QALYs when compared against exenatide QW for the treatment of T2DM in France. Compared with exenatide QW, dulaglutide 1.5 mg can provide additional health benefits for patients with T2DM and may result in cost savings for payers. Eli Lilly." @default.
• W2770973170 created "2017-12-04" @default.
• W2770973170 creator A5004782335 @default.
• W2770973170 creator A5007243277 @default.
• W2770973170 creator A5029923691 @default.
• W2770973170 creator A5052278265 @default.
• W2770973170 creator A5070145722 @default.
• W2770973170 creator A5075771608 @default.
• W2770973170 creator A5079868402 @default.
• W2770973170 creator A5091439412 @default.
• W2770973170 date "2017-11-13" @default.
• W2770973170 modified "2023-10-17" @default.
• W2770973170 title "The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France" @default.
• W2770973170 cites W126610468 @default.
• W2770973170 cites W1980913786 @default.
• W2770973170 cites W2020572030 @default.
• W2770973170 cites W2030546890 @default.
• W2770973170 cites W2039713231 @default.
• W2770973170 cites W2054981500 @default.
• W2770973170 cites W2059909265 @default.
• W2770973170 cites W2067626357 @default.
• W2770973170 cites W2068250128 @default.
• W2770973170 cites W2076583826 @default.
• W2770973170 cites W2090054860 @default.
• W2770973170 cites W2104252114 @default.
• W2770973170 cites W2109257319 @default.
• W2770973170 cites W2112537103 @default.
• W2770973170 cites W2122178496 @default.
• W2770973170 cites W2125776201 @default.
• W2770973170 cites W2127622911 @default.
• W2770973170 cites W2131649684 @default.
• W2770973170 cites W2139634859 @default.
• W2770973170 cites W2149185313 @default.
• W2770973170 cites W2152984355 @default.
• W2770973170 cites W2157606430 @default.
• W2770973170 cites W2165556241 @default.
• W2770973170 cites W2169355652 @default.
• W2770973170 cites W2199038420 @default.
• W2770973170 cites W2260254013 @default.
• W2770973170 cites W2302447233 @default.
• W2770973170 cites W2337454357 @default.
• W2770973170 cites W3146544362 @default.
• W2770973170 cites W906438903 @default.
• W2770973170 doi "https://doi.org/10.1007/s13300-017-0321-0" @default.
• W2770973170 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5801216" @default.
• W2770973170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29134607" @default.
• W2770973170 hasPublicationYear "2017" @default.
• W2770973170 type Work @default.
• W2770973170 sameAs 2770973170 @default.
• W2770973170 citedByCount "11" @default.
• W2770973170 countsByYear W27709731702015 @default.
• W2770973170 countsByYear W27709731702019 @default.
• W2770973170 countsByYear W27709731702020 @default.
• W2770973170 countsByYear W27709731702022 @default.
• W2770973170 countsByYear W27709731702023 @default.
• W2770973170 crossrefType "journal-article" @default.
• W2770973170 hasAuthorship W2770973170A5004782335 @default.
• W2770973170 hasAuthorship W2770973170A5007243277 @default.
• W2770973170 hasAuthorship W2770973170A5029923691 @default.
• W2770973170 hasAuthorship W2770973170A5052278265 @default.
• W2770973170 hasAuthorship W2770973170A5070145722 @default.
• W2770973170 hasAuthorship W2770973170A5075771608 @default.
• W2770973170 hasAuthorship W2770973170A5079868402 @default.
• W2770973170 hasAuthorship W2770973170A5091439412 @default.
• W2770973170 hasBestOaLocation W27709731701 @default.
• W2770973170 hasConcept C112930515 @default.
• W2770973170 hasConcept C126322002 @default.
• W2770973170 hasConcept C134018914 @default.
• W2770973170 hasConcept C2777180221 @default.
• W2770973170 hasConcept C2779829264 @default.
• W2770973170 hasConcept C2780533449 @default.
• W2770973170 hasConcept C2910068830 @default.
• W2770973170 hasConcept C3019080777 @default.
• W2770973170 hasConcept C515549039 @default.
• W2770973170 hasConcept C555293320 @default.
• W2770973170 hasConcept C71924100 @default.
• W2770973170 hasConceptScore W2770973170C112930515 @default.
• W2770973170 hasConceptScore W2770973170C126322002 @default.
• W2770973170 hasConceptScore W2770973170C134018914 @default.
• W2770973170 hasConceptScore W2770973170C2777180221 @default.
• W2770973170 hasConceptScore W2770973170C2779829264 @default.
• W2770973170 hasConceptScore W2770973170C2780533449 @default.
• W2770973170 hasConceptScore W2770973170C2910068830 @default.
• W2770973170 hasConceptScore W2770973170C3019080777 @default.
• W2770973170 hasConceptScore W2770973170C515549039 @default.
• W2770973170 hasConceptScore W2770973170C555293320 @default.
• W2770973170 hasConceptScore W2770973170C71924100 @default.
• W2770973170 hasFunder F4320307758 @default.
• W2770973170 hasIssue "1" @default.
• W2770973170 hasLocation W27709731701 @default.
• W2770973170 hasLocation W27709731702 @default.
• W2770973170 hasLocation W27709731703 @default.
• W2770973170 hasLocation W27709731704 @default.
• W2770973170 hasOpenAccess W2770973170 @default.
• W2770973170 hasPrimaryLocation W27709731701 @default.
• W2770973170 hasRelatedWork W2166886145 @default.
• W2770973170 hasRelatedWork W2196942236 @default.
• W2770973170 hasRelatedWork W2317005372 @default.

• next